Check the winners The Grow Awards 2026 🏆
Lemon Cherry Zeelosa

Lemon Cherry Zeelosa

0 oogsten
hybrid
Genen
23%
THC
0.1%
CBD
Shuga Seeds
Stam Creator
0 oogsten
hybrid
Genen
23%
THC
0.1%
CBD
Shuga Seeds
Stam Creator

Lemon Cherry Zeelosa is an Indica-driven hybrid, brought to the world by Spain-based company Shuga Seeds. It’s the result of crossbreeding Lemon Cherry Celosa with The Original Z (AKA Zkittlez). What we get from this marriage is a flavorful strain guaranteed to put you in the best mood imaginable for hours on end. Regarding aroma and flavor, Lemon Cherry Zeelosa delivers a mouthwatering blend of sweet and candy-like sensations, so expect freshly picked berries, cherries, grapes, and citrus. In terms of medical usage, Lemon Cherry Zeelosa holds the most promise for patients seeking alternative ways to deal with depression, acute or chronic stress, and a lack of appetite. Consumers should know that the Lemon Cherry Zeelosa high brings a wave of relaxation and happiness without becoming overwhelming. This cultivar is a great choice for any time of day, but it’s more relaxing than uplifting. Expect a giggly mindset, mild sedation, and a possible case of the munchies. Growers should know that these highly aromatic plants showcase vigorous growth, reach medium heights, and need between 60 and 65 days of flowering. LST, strategic pruning for improved airflow, and odor control are highly recommended.

Show more
Positieve effecten:
Negatieve effecten:
Indica Sleepy
Sativa Energy
Laag THC Normaal
Hoge THC Krachtig

Stamboom


Lemon Cherry Zeelosa Breeder products




Vergelijken met Lemon Cherry Zeelosa

Type
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Cannabinoïde
THC 23%
THC 23%
THC 0.3%
THC 24%
THC 26%
THC 30%
THC 34%
THC 26%
THC 26.5%
THC 20%
Top Effect
Happy
Uplifted
Uplifted
Uplifted
Uplifted
Uplifted
Uplifted
Euphoric
Energetic
Uplifted
Dominante terpeen
Myrcene
Limonene
Limonene
Caryophyllene
Limonene
Caryophyllene
Limonene
Caryophyllene
Caryophyllene
Limonene





Inloggen

Wees de eerste om het te reageren